Technological development and advances in single-photon emission computed tomography/computed tomography

Y Seo, C Mari, BH Hasegawa - Seminars in nuclear medicine, 2008 - Elsevier
Single-photon emission computed tomography/computed tomography (SPECT/CT) has
emerged during the past decade as a means of correlating anatomical information from CT …

ICRU REPORT 96, dosimetry-guided radiopharmaceutical therapy

G Sgouros, WE Bolch, A Chiti… - Journal of the …, 2021 - journals.sagepub.com
The International Commission on Radiation Units and Measurements (ICRU), since its
inception in 1925, has had as its principal objective the development of internationally …

[HTML][HTML] Targeted radionuclide therapy

D Ersahin, I Doddamane, D Cheng - Cancers, 2011 - mdpi.com
Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing
of cancer cells is achieved with the use of biological vectors and appropriate radionuclides …

Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y

H Song, RF Hobbs, R Vajravelu, DL Huso, C Esaias… - Cancer research, 2009 - AACR
Abstract α-Particles are suitable to treat cancer micrometastases because of their short
range and very high linear energy transfer. α-Particle emitter 213Bi-based …

Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice

HA Jacene, R Filice, W Kasecamp… - Journal of Nuclear …, 2007 - Soc Nuclear Med
We retrospectively evaluated our single-center clinical experience with 90Y-ibritumomab
tiuxetan and 131I-tositumomab for therapy of refractory non-Hodgkin's lymphoma (NHL). We …

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

DX Fu, Y Tanhehco, J Chen, CA Foss, JJ Fox… - Nature medicine, 2008 - nature.com
We investigated the possibility of using a pharmacologic agent to modulate viral gene
expression to target radiotherapy to tumor tissue. In a mouse xenograft model, we had …

In vitro characterization of 177Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study

F Forrer, J Chen, M Fani, P Powell, A Lohri… - European journal of …, 2009 - Springer
Abstract Purpose 131 I-and 90 Y-labelled anti-CD20 antibodies have been shown to be
effective in the treatment of low-grade, B-cell non-Hodgkin's lymphoma (NHL). However, the …

Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma

T Cazaentre, F Morschhauser, M Vermandel… - European journal of …, 2010 - Springer
Purpose Radioimmunotherapy (RIT) is a new treatment option for patients with non-Hodgkin
lymphoma (NHL). Response to RIT currently remains difficult to predict using conventional …

[HTML][HTML] Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy

J Högberg, M Rizell, R Hultborn, J Svensson… - EJNMMI research, 2014 - Springer
Background Selective arterial radioembolisation of liver tumours has increased, because of
encouraging efficacy reports; however, therapeutic parameters used in external beam …

18F-FDG PET/CT for monitoring the response of lymphoma to radioimmunotherapy

HA Jacene, R Filice, W Kasecamp… - Journal of Nuclear …, 2009 - Soc Nuclear Med
We retrospectively evaluated 18F-FDG PET/CT for monitoring the response of non-
Hodgkin's lymphoma to radioimmunotherapy. Methods: A total of 33 clinical patients …